The application of molecular modelling in the safety assessment of chemicals: A case study on ligand-dependent PPARγ dysregulation-Reference-Cited by-同舟云学术

The application of molecular modelling in the safety assessment of chemicals: A case study on ligand-dependent PPARγ dysregulation

Published:2017-12 Issue: Volume:392 Page:140-154
ISSN:0300-483X
Container-title:Toxicology
language:en
Short-container-title:Toxicology

Author:

Al Sharif Merilin,Tsakovska Ivanka,Pajeva Ilza,Alov Petko,Fioravanzo Elena,Bassan Arianna,Kovarich Simona,Yang Chihae,Mostrag-Szlichtyng Aleksandra,Vitcheva Vessela,Worth Andrew P.,Richarz Andrea-N.,Cronin Mark T.D.

Funder

European Community’s 7th Framework Program

Cosmetics Europe

Publisher

Elsevier BV

Subject

Toxicology

Reference59 articles.

1. ACD/Labs Percepta suite, 2015. Advanced Chemistry Development, Inc. http://www.acdlabs.com/products/percepta/.

2. Benzoyl 2-methyl indoles as selective PPARγ modulators;Acton;Bioorg. Med. Chem. Lett.,2005

3. Adverse Outcome Pathway Knowledge Base (AOP-KB), 2015. https://aopkb.org/ (accessed July, 2015).

4. Modes-of-action related to repeated dose toxicity: tissue-specific biological roles of PPARγ ligand-dependent dysregulation in nonalcoholic fatty liver disease;Al Sharif;PPAR Res.,2014

5. Discovery of new nanomolar peroxisome proliferator-activated receptor γ activators via elaborate ligand-based modeling;Al-Najjar;Eur. J. Med. Chem.,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial screening and molecular docking of synthesized 4,6-di(1H-indol-3-yl)-1,6-dihydropyrimidin-2-amine;Intelligent Pharmacy;2024-08

2. Identification of molecular initiating events (MIE) using chemical database analysis and nuclear receptor activity assays for screening potential inhalation toxicants;Regulatory Toxicology and Pharmacology;2023-06

3. Multi-step structure-activity relationship screening efficiently predicts diverse PPARγ antagonists;Chemosphere;2022-01

4. Evidenced-Based Approaches to Support the Development of Endocrine-Mediated Adverse Outcome Pathways: Challenges and Opportunities;Frontiers in Toxicology;2021-12-21

5. In silico Studies of Biologically Active Molecules;Studies in Computational Intelligence;2021